SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000919574-20-001125
Filing Date
2020-02-13
Accepted
2020-02-13 17:19:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8472500.htm SC 13G/A 125930
  Complete submission text file 0000919574-20-001125.txt   127368
Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2460
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

IRS No.: 202924429 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89137 | Film No.: 20612085
SIC: 2834 Pharmaceutical Preparations